Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115703487 | 11570348 | 7 | F | 20150123 | 20160902 | 20150929 | 20160913 | EXP | US-CELGENEUS-USA-2015096172 | CELGENE | 17.33 | YR | M | Y | 0.00000 | 20160913 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115703487 | 11570348 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | 250 MILLIGRAM | U | UNKNOWN | 20785 | 250 | MG | CAPSULES | QD | ||||
| 115703487 | 11570348 | 2 | SS | THALOMID | THALIDOMIDE | 1 | U | UNKNOWN | 20785 | ||||||||||
| 115703487 | 11570348 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Oral | U | 0 | UNKNOWN | |||||||||
| 115703487 | 11570348 | 4 | SS | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 115703487 | 11570348 | 5 | SS | Celecox | CELECOXIB | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 115703487 | 11570348 | 6 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Oral | U | 0 | UNKNOWN | |||||||||
| 115703487 | 11570348 | 7 | SS | AVASTIN | BEVACIZUMAB | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 115703487 | 11570348 | 8 | C | Filgrastim | FILGRASTIM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 115703487 | 11570348 | 9 | C | Morphine | MORPHINE | 1 | Unknown | 0 | 2 | MG | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115703487 | 11570348 | 1 | Brain neoplasm malignant |
| 115703487 | 11570348 | 2 | Atypical teratoid/rhabdoid tumour of CNS |
| 115703487 | 11570348 | 3 | Product used for unknown indication |
| 115703487 | 11570348 | 4 | Product used for unknown indication |
| 115703487 | 11570348 | 5 | Product used for unknown indication |
| 115703487 | 11570348 | 6 | Product used for unknown indication |
| 115703487 | 11570348 | 7 | Product used for unknown indication |
| 115703487 | 11570348 | 8 | Colony stimulating factor therapy |
| 115703487 | 11570348 | 9 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115703487 | 11570348 | LT |
| 115703487 | 11570348 | DE |
| 115703487 | 11570348 | HO |
| 115703487 | 11570348 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115703487 | 11570348 | Atypical teratoid/rhabdoid tumour of CNS | |
| 115703487 | 11570348 | Bone marrow failure | |
| 115703487 | 11570348 | Cardiopulmonary failure | |
| 115703487 | 11570348 | Escherichia sepsis | |
| 115703487 | 11570348 | Multiple organ dysfunction syndrome | |
| 115703487 | 11570348 | Pneumonia influenzal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115703487 | 11570348 | 1 | 20141210 | 20150123 | 0 | |
| 115703487 | 11570348 | 8 | 20150131 | 0 | ||
| 115703487 | 11570348 | 9 | 201501 | 201501 | 0 |